COPD management for stabilization

Masakazu Ichinose

Research output: Contribution to journalArticlepeer-review

Abstract

In addition to smoking cessation and regular influenza vaccination, pharmacotherapy is used to treat COPD patients. Long-acting bronchodilators are central to COPD therapy since they reduce patient symptoms such as dyspnea, facilitate an increase in physical activity, and prevent disease exacerbation. The severity of COPD is determined according to the patient's dyspnea, exercise capacity, physical activity, and exacerbation frequency. Pulmonary rehabilitation and drug therapy are effective for facilitating increases in the physical activity of COPD patients.

Original languageEnglish
Pages (from-to)1219-1227
Number of pages9
JournalJapanese Journal of Chest Diseases
Volume72
Issue number11
Publication statusPublished - 2013

Keywords

  • Bronchodilator
  • Cessation
  • Dyspnea
  • Exacerbation
  • Physical activity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'COPD management for stabilization'. Together they form a unique fingerprint.

Cite this